Download PDF
CC BY-NC-ND 4.0 · Eur J Dent 2016; 10(04): 546-550
DOI: 10.4103/1305-7456.195179
Original Article
Dental Investigation Society

Gingival crevicular fluid periostin levels in chronic periodontitis patients following nonsurgical periodontal treatment with low-level laser therapy

Dhanangchaayan Kumaresan
1   Department of Periodontology, SRM Dental College and Hospital, Chennai, Tamil Nadu, India
,
Aruna Balasundaram
1   Department of Periodontology, SRM Dental College and Hospital, Chennai, Tamil Nadu, India
,
Vanaja Krishna Naik
1   Department of Periodontology, SRM Dental College and Hospital, Chennai, Tamil Nadu, India
,
Deva Priya Appukuttan
1   Department of Periodontology, SRM Dental College and Hospital, Chennai, Tamil Nadu, India
› Author Affiliations
Further Information

Publication History

Publication Date:
24 September 2019 (online)

  PDF Download Permissions and Reprints

ABSTRACT

Objective: Periostin is a matricellular protein highly expressed in periosteum, periodontal ligament and is essential for tissue integrity and maturation. It plays a role in collagen fibrillogenesis and is downregulated in periodontal disease. Biostimulation utilizing low-level laser therapy (LLLT) influences periodontal ligament fibroblast proliferation. This study was conducted with the objective of estimating periostin levels in chronic periodontitis (CP) patients following LLLT as an adjunct to root surface debridement (RSD). Materials and Methods: Thirty periodontally healthy participants (Group I) and sixty CP participants were recruited. Based on the therapeutic intervention, CP patients were allocated to either RSD (Group II) or to RSD with LLLT (Group III) group. Clinical parameters and gingival crevicular fluid (GCF) periostin levels were assessed at the baseline and at the 3rd month. Results: Periostin levels were significantly lower in CP patients when compared to healthy individuals at the baseline (P < 0.01). Following nonsurgical periodontal treatment (NSPT), periostin levels significantly increased in both Group II and III, when compared to baseline values (P < 0.001). Comparison of mean periostin levels between both the treatment groups showed a significant increase in LLLT group than RSD at the 3rd month (P < 0.05). Conclusion: Within the limitations of the present study, LLLT application was found to have additional benefits over RSD with respect to clinical periodontal parameters and GCF periostin levels. Moreover, periostin may be used as a possible biomarker to evaluate the outcome following NSPT.

Key words:

Enzyme Linked Immunosorbent Assay - fibrillogenesis - gingival crevicular fluid - low-level laser - periostin
 

  • REFERENCES

  • 1 Erdemir EO, Hendek MK, Keceli HG, Apan TZ. Crevicular fluid levels of interleukin-8, interleukin-17 and soluble intercellular adhesion molecule-1 after regenerative periodontal therapy. Eur J Dent 2015; 9: 60-5
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H. et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999; 14: 1239-49
    CrossrefPubMedGoogle Scholar
  • 3 Kudo A. Periostin in fibrillogenesis for tissue regeneration: Periostin actions inside and outside the cell. Cell Mol Life Sci 2011; 68: 3201-7
    CrossrefPubMedGoogle Scholar
  • 4 Padial-Molina M, Volk SL, Taut AD, Giannobile WV, Rios HF. Periostin is down-regulated during periodontal inflammation. J Dent Res 2012; 91: 1078-84
    Google Scholar
  • 5 Rios HF, Ma D, Xie Y, Giannobile WV, Bonewald LF, Conway SJ. et al. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol 2008; 79: 1480-90
    CrossrefPubMedGoogle Scholar
  • 6 Padial-Molina M, Volk SL, Rios HF. Periostin increases migration and proliferation of human periodontal ligament fibroblasts challenged by tumor necrosis factor – A and Porphyromonas gingivalis lipopolysaccharides. J Periodontal Res 2014; 49: 405-14
    CrossrefPubMedGoogle Scholar
  • 7 Padial-Molina M, Volk SL, Rodriguez JC, Marchesan JT, Galindo-Moreno P, Rios HF. Tumor necrosis factor-a and Porphyromonas gingivalis lipopolysaccharides decrease periostin in human periodontal ligament fibroblasts. J Periodontol 2013; 84: 694-703
    CrossrefPubMedGoogle Scholar
  • 8 Stein E, Koehn J, Sutter W, Wendtlandt G, Wanschitz F, Thurnher D. et al. Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells. Wien Klin Wochenschr 2008; 120: 112-7
    CrossrefPubMedGoogle Scholar
  • 9 Qadri T, Miranda L, Tunér J, Gustafsson A. The short-term effects of low-level lasers as adjunct therapy in the treatment of periodontal inflammation. J Clin Periodontol 2005; 32: 714-9
    CrossrefPubMedGoogle Scholar
  • 10 Aykol G, Baser U, Maden I, Kazak Z, Onan U, Tanrikulu-Kucuk S. et al. The effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment. J Periodontol 2011; 82: 481-8
    CrossrefPubMedGoogle Scholar
  • 11 Lukashev ME, Werb Z. ECM signalling: Orchestrating cell behaviour and misbehaviour. Trends Cell Biol 1998; 8: 437-41
    CrossrefPubMedGoogle Scholar
  • 12 Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, Moreno-Rodriguez R. et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007; 101: 695-711
    CrossrefPubMedGoogle Scholar
  • 13 Yu HS, Chang KL, Yu CL, Chen JW, Chen GS. Low-energy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured human keratinocytes. J Invest Dermatol 1996; 107: 593-6
    CrossrefPubMedGoogle Scholar
  • 14 Almeida-Lopes L, Rigau J, Amaro ZângaroR, Guidugli-Neto J, Marques JaegerMM. Comparison of the low level laser therapy effects on cultured human gingival fibroblasts proliferation using different irradiance and same fluence. Lasers Surg Med 2001; 29: 179-84
    CrossrefPubMedGoogle Scholar
  • 15 Padial-Molina M, Volk SL, Rios HF. Preliminary insight into the periostin leverage during periodontal tissue healing. J Clin Periodontol 2015; 42: 764-772
    CrossrefPubMedGoogle Scholar
  • 16 Aral CA, Köseoğlu S, Sağlam M, Pekbağrıyanık T, Savran L. Gingival crevicular fluid and salivary periostin levels in non-smoker subjects with chronic and aggressive periodontitis: Periostin levels in chronic and aggressive periodontitis. Inflammation 2016; 39: 986-93
    PubMedGoogle Scholar
  • 17 Balli U, Keles ZP, Avci B, Guler S, Cetinkaya BO, Keles GC. Assessment of periostin levels in serum and gingival crevicular fluid of patients with periodontal disease. J Periodontal Res 2015; 50: 707-13
    CrossrefPubMedGoogle Scholar
  • 18 da Silva-Boghossian CM, do Souto RM, Luiz RR, Colombo AP. Association of red complex, A. actinomycetemcomitans and non-oral bacteria with periodontal diseases. Arch Oral Biol 2011; 56: 899-906
    CrossrefPubMedGoogle Scholar
  • 19 Moritz A, Schoop U, Goharkhay K, Schauer P, Doertbudak O, Wernisch J. et al. Treatment of periodontal pockets with a diode laser. Lasers Surg Med 1998; 22: 302-11
    CrossrefPubMedGoogle Scholar
  • 20 Saafan A, El-Nahass H, Nasr AS, Radwan R. Effect of low power diode laser 810 nm on TGF-β1 level in GCF in aggressive periodontitis. J Dent Lasers 2013; 7: 59
    CrossrefGoogle Scholar
  • 21 Schwarz F, Aoki A, Becker J, Sculean A. Laser application in non-surgical periodontal therapy: A systematic review. J Clin Periodontol 2008; 35 (08) Suppl 29-44
    CrossrefPubMedGoogle Scholar
  • 22 Sgolastra F, Severino M, Gatto R, Monaco A. Effectiveness of diode laser as adjunctive therapy to scaling root planning in the treatment of chronic periodontitis: A meta-analysis. Lasers Med Sci 2013; 28: 1393-402
    CrossrefPubMedGoogle Scholar